Source:http://linkedlifedata.com/resource/pubmed/id/12163500
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
41
|
pubmed:dateCreated |
2002-10-7
|
pubmed:abstractText |
Surfactant protein D (SP-D) gene-targeted mice develop severe pulmonary disease associated with emphysema, pulmonary lipidosis, and foamy macrophage infiltrations. To determine the potential reversibility of these abnormalities, transgenic mice were developed in which SP-D was conditionally replaced in the respiratory epithelium of SP-D(-/-) mice. SP-D was not detected in the absence of doxycycline. Treatment with doxycycline after birth restored pulmonary SP-D concentrations and corrected pulmonary pathology at adulthood. When SP-D was replaced in adult SP-D(-/-) mice, alveolar SP-D was restored within 3 days, pulmonary lipid abnormalities were corrected, but emphysema persisted. In corrected adult SP-D(-/-) mice, loss of SP-D caused focal emphysema and pulmonary inflammation but did not cause phospholipid abnormalities characteristic of SP-D(-/-) mice. Thus, abnormalities in surfactant phospholipid homeostasis and alveolar macrophage abnormalities were readily corrected by restoration of SP-D. However, once established, emphysema was not reversed by SP-D. SP-D-dependent processes regulating surfactant lipid homeostasis were disassociated from those mediating emphysema.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Doxycycline,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipids,
http://linkedlifedata.com/resource/pubmed/chemical/Pulmonary Surfactant-Associated...,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
11
|
pubmed:volume |
277
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
38709-13
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12163500-Animals,
pubmed-meshheading:12163500-Anti-Bacterial Agents,
pubmed-meshheading:12163500-Doxycycline,
pubmed-meshheading:12163500-Emphysema,
pubmed-meshheading:12163500-Homeostasis,
pubmed-meshheading:12163500-Lung,
pubmed-meshheading:12163500-Macrophages,
pubmed-meshheading:12163500-Mice,
pubmed-meshheading:12163500-Mice, Transgenic,
pubmed-meshheading:12163500-Neutrophils,
pubmed-meshheading:12163500-Phospholipids,
pubmed-meshheading:12163500-Pulmonary Surfactant-Associated Protein D,
pubmed-meshheading:12163500-Rats,
pubmed-meshheading:12163500-Recombinant Proteins,
pubmed-meshheading:12163500-Time Factors
|
pubmed:year |
2002
|
pubmed:articleTitle |
Reversibility of pulmonary abnormalities by conditional replacement of surfactant protein D (SP-D) in vivo.
|
pubmed:affiliation |
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|